Treatment of scleroderma skin ulcers using becaplermin gel and hydrocolloid membrane

Journal of the American Podiatric Medical Association

Volumn 92, Issue 6, 2002, Pages 350-354

  Yoon, Jerry ^a,b   Giacopelli, Joseph ^a,b,c,d   Granoff, David ^a,b,c,d   Kobayashi, Wesley ^b,c,d  

^a Fountain Valley Regional Hospital and Medical Center   (United States)

^b American Board of Podiatric Surgery ^*

^c AMERICAN BOARD OF PODIATRIC SURGERY   (United States)

^d American College of Foot and Ankle Surgeons   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB; PREDNISONE; RECOMBINANT PROTEIN;

ARTICLE; ARTIFICIAL MEMBRANE; BANDAGE; CASE REPORT; COLLOID; DRUG EFFECT; FEMALE; GEL; HUMAN; LEG ULCER; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SYSTEMIC SCLEROSIS; WOUND HEALING;

BANDAGES; COLLOIDS; COMBINED MODALITY THERAPY; FEMALE; GELS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEG ULCER; MEMBRANES, ARTIFICIAL; MIDDLE AGED; PLATELET-DERIVED GROWTH FACTOR; PREDNISONE; RECOMBINANT PROTEINS; SCLERODERMA, SYSTEMIC; WOUND HEALING;

EID: 0036599368     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-92-6-350     Document Type: Review

References (16)

1. MARICQ HR, SMITH EA: "Organ Involvement: Peripheral Vascular," in Systemic Sclerosis, ed by PJ Clements, DE Furst, p 365, Williams & Wilkins, Baltimore, 1996.
2. RODNAN GP, MYEROWITZ RL, JUSTH GO: Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon. Medicine 59: 393, 1980.
3. VON BIERBRAUER A, BARTH P, WILLERT J, ET AL: Electron microscopy and capillaroscopically guided nailfold biopsy in connective tissue diseases: detection of ultrastructural changes of the microcirculatory vessels. Br J Rheum 37: 1272, 1998.
4. AMES PR, LUPOLI S, ALVES J, ET AL: The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheum 36: 1045, 1997.
5. MARICQ HR: Wide-field capillary microscopy: technique and rating scale for abnormalities seen in scleroderma and related disorders. Arthritis Rheum 24: 1159, 1981.
6. CLEMENTS PJ, MEDSGER TA JR: "Organ Involvement: Skin," in Systemic Sclerosis, ed by PJ Clements, DE Furst, p 389, Williams & Wilkins, Baltimore, 1996.
7. MILBURN PB, SINGER JZ, MILBURN MA: Treatment of scleroderma skin ulcers with a hydrocolloid membrane. J Am Acad Dermatol 21: 200, 1989.
8. ZACHARIAE H, HALKIER-SORENSEN L, BJERRING P, ET AL: Treatment of ischaemic digital ulcers and prevention of gangrene with intravenous iloprost in systemic sclerosis. Acta Derm Venereol 76: 236, 1996.
9. WOO TY, WONG RC, CAMPBELL JP, ET AL: Nifedipine in scleroderma ulcerations. Int J Dermatol 23: 678, 1984.
10. AMES PR, STEPHENS JW, STEUER A, ET AL: Prolonged healing of malleolar ulcers after fibrinolytic treatment in a woman with systemic sclerosis. Br J Rheumatol 37: 107, 1998.
11. HAFNER J, KOHLER A, ENZLER M, ET AL: Successful treatment of an extended leg ulcer in systemic sclerosis. Vasa 26: 302, 1997.
12. DOREVITCH MI, CLEMENS LE, WEBB JB: Lower limb amputation secondary to large vessel involvement in scleroderma. Br J Rheumatol 27: 403, 1988.
13. FILHO JP, SAMPAIO-BARROS PD, PARENTE JB, ET AL: Rhythmic external compression of the limbs: a method for healing cutaneous ulcers in systemic sclerosis. J Rheumatol 25: 1540, 1998.
14. Platelet-derived growth factor for diabetic ulcers. Med Lett Drugs Ther 40: 73, 1998.
15. LEGRAND EK: Preclinical promise of becaplermin (rh-PDGF-BB) in wound healing. Am J Surg 176 (suppl 2A): 48S, 1998.
16. WIEMAN TJ, SMIELL JM, SU Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care 21: 822, 1998.